恶性炎的叙述性综述:流行病学,病理生理学,评估和治疗
Takako Ikegami1, Hiroto Ishiki2, Toru Kadono3
1Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Annals of palliative medicine
|April 22, 2024
概括
恶性炎 (MA) 管理对于经历痛苦症状的晚期癌症患者至关重要. 目前的治疗方法各不相同,但由于研究有限,没有标准的指导方针,需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 抚慰性护理是一种缓解性护理.
背景情况:
- 恶性炎 (MA) 影响大约60%的晚期癌症患者,造成严重的痛苦.
- 马氏体是一个公认的不良预后指标,强调需要有效的管理策略.
研究的目的:
- 进行关于恶性风的现有文献的叙事综合.
- 审查MA的病理生理学,当前的治疗方法和症状管理.
主要方法:
- 在PubMed和Cochrane图书馆进行了全面的文献搜索.
- 在1971年至2023年5月期间发表的专注于恶性瘤的文章被审查和总结.
主要成果:
- 病理生理学涉及增加的血管透性和受损的淋巴排水.
- 治疗包括利尿剂,,腹腔内疗法,变位,和设备,如alfapump.
- 胸腔外围止痛可以缓解风相关的症状.
结论:
- 由于临床试验的稀缺性,对MA没有确立的标准治疗方法.
- 进一步的研究和开发新型治疗方法对于改善MA患者的治疗结果至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Pleural Effusion II: Symptoms and Management
166
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
166
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122
Esophageal Varices-I: Introduction
124
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
124


